| Adherence and associated factors of treatment regimen in drug-susceptible tuberculosis patients S Bea, H Lee, JH Kim, SH Jang, H Son, JW Kwon, JY Shin Frontiers in pharmacology 12, 625078, 2021 | 46 | 2021 |
| Risk of thyroid cancer associated with glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A population‐based … S Bea, H Son, JH Bae, SW Cho, JY Shin, YM Cho Diabetes, Obesity and Metabolism 26 (1), 108-117, 2024 | 11 | 2024 |
| Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South … HE Jeong, S Park, Y Noh, S Bea, KB Filion, OHY Yu, SH Jang, YM Cho, ... BMC medicine 21 (1), 47, 2023 | 7 | 2023 |
| Socioeconomic disparities and multidrug-resistant tuberculosis in South Korea: Focus on immigrants and income levels HE Jeong, S Bea, JH Kim, SH Jang, H Son, JY Shin Journal of Microbiology, Immunology and Infection 56 (2), 424-428, 2023 | 5 | 2023 |
| Changes on physicochemical and matcha quality of tea leaves (Camellia sinensis) under shading cultivation JG Hwang, DB Shim, HJ Im, SK Park, EJ Kang, KH Cho, SK Bea, JH Lee, ... J Kor Tea Soc 24, 40-493, 2018 | 5 | 2018 |
| Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study S Bea, HE Jeong, S Park, HY Oriana, Y Chang, J Cho, DH Sinn, YM Cho, ... Gut 72 (5), 1020-1022, 2023 | 4 | 2023 |
| Sodium-glucose cotransporter-2 inhibitors and risk of hepatocellular carcinoma among patients with type 2 diabetes S Bea, HE Jeong, JH Kim, OH Yu, L Azoulay, JY Shin Clinical Gastroenterology and Hepatology 21 (13), 3451-3454. e4, 2023 | 2 | 2023 |
| Comparative safety of bedaquiline and delamanid in patients with multidrug resistant tuberculosis: A nationwide retrospective cohort study JH Kim, H Lee, IS Oh, HE Jeong, S Bea, SH Jang, H Son, JY Shin Journal of Microbiology, Immunology and Infection 56 (4), 842-852, 2023 | 2 | 2023 |
| Autoimmune disorders reported following COVID-19 vaccination: A disproportionality analysis using the WHO database S Kim, S Bea, SA Choe, NK Choi, JY Shin European Journal of Clinical Pharmacology, 1-9, 2024 | 1 | 2024 |
| Cognitive dysfunction following finasteride use: a disproportionality analysis of the global pharmacovigilance database Y Cho, S Bea, JH Bae, DH Kim, JH Lee, JY Shin Expert Opinion on Drug Safety, 1-7, 2023 | 1 | 2023 |
| Outcomes of SGLT-2i and GLP-1RA Therapy Among Patients With Type 2 Diabetes and Varying NAFLD Status S Bea, HE Jeong, KB Filion, HY Oriana, YM Cho, BH Lee, Y Chang, ... JAMA Network Open 6 (12), e2349856-e2349856, 2023 | 1 | 2023 |
| Safety of sodium‐glucose co‐transporter‐2 inhibitors on amputation across categories of baseline cardiovascular disease and diuretics use in patients with type 2 diabetes S Park, HE Jeong, S Bea, OHY Yu, YM Cho, SC You, KKC Man, JY Shin Diabetes, Obesity and Metabolism 25 (11), 3248-3258, 2023 | 1 | 2023 |
| Sodium-glucose cotransporter 2 inhibitors vs incretin-based drugs and risk of fractures for type 2 diabetes HY Ko, S Bea, HE Jeong, S Park, YM Cho, SH Kong, JY Shin JAMA network open 6 (9), e2335797-e2335797, 2023 | 1 | 2023 |
| Risk of breakthrough SARS‐CoV‐2 infection and clinical outcomes among vaccinated patients with type 2 diabetes S Bea, A Choi, JH Kim, YM Cho, WS Choi, J Jung, JY Shin Diabetes, Obesity and Metabolism 25 (9), 2734-2742, 2023 | 1 | 2023 |
| Risk of mortality and clinical outcomes associated with healthcare delay among patients with tuberculosis S Bea, H Lee, WS Choi, K Huh, J Jung, JY Shin Journal of Infection and Public Health 16 (8), 1313-1321, 2023 | 1 | 2023 |
| A study of the regional differences in propacetamol-related adverse events using VigiBase data of the World Health Organization HE Jeong, S Bea, D Yoon, J Jung, SM Park, J Jeon, YM Ye, JH Lee, ... Scientific Reports 12 (1), 21568, 2022 | 1 | 2022 |
| Exploring the perception on Drug Utilization Review System and DUR modernization pilot project: A qualitative study using focus group interviews S Bea, HL Jeon, D Yoon, A Choi, H Lee, JY Shin Korean Journal of Clinical Pharmacy 31 (2), 104-114, 2021 | 1 | 2021 |
| Comparative effectiveness and safety of ticagrelor and clopidogrel in patients with or without chronic liver disease: a nationwide cohort study B Hong, S Bea, SC You, Y Chang, W Kim, JY Shin The American Journal of Medicine, 2024 | | 2024 |
| Predictors, mortality, and health outcomes of intensive phase non-adherence to a regimen in patients with drug-susceptible tuberculosis: a nationwide linkage database H Lee, S Bea, JH Kim, HE Jeong, SH Jang, H Son, JY Shin Public Health 229, 167-175, 2024 | | 2024 |
| Effectiveness of axicabtagene ciloleucel versus conventional treatments as first-line therapy for high-risk large B-cell lymphoma: an external comparator study JY Shin, JH Kim, S Bea, Y Choi, SE Yoon, WS Kim, SJ Kim | | 2024 |
